EFFICACY OF TRIAMCINOLONE ACETONIDE INTRALESIONAL INJECTION IN THE TREATMENT OF NAIL PSORIASIS
Main Article Content
Abstract
Objectives: To evaluate efficacy of triamcinolone acetonide intralesional injection in the treatment of nail psoriasis.
Methods: Non-controlled interventional study on 79 nails of 11 psoriasis patients at National Hospital of Dermatology and Venereology from August 2020 to August 2021.
Results: Amount of pitting lesion was 67 nails at baseline, which statistically significant decrease at the 2nd month with 57 nails (p=0.016) and at the 4th month with 54 nails (p=0.014), however there was no difference between the 2nd and 4th month (p=0.192); while, there was no difference in transverse ridging, crumbling, leukonychia at the 2nd and 4th months. Amount of subungual hyperkeratosis was 61 nails at baseline, statistically significant decrease at the 2nd month with 52 nails (p=0.031) and the 4th month with 50 nails (p=0.019), however there is no difference between the 2nd and 4th month (p=0.167); there was no difference in oil drops, onycholysis, and splinter hemorrhage at 2nd and 4th months. Nail Psoriasis Severity Index (NAPSI) decreased statistically at 2nd months with an average decrease of 5.1±6.5 (p=0.000) and continued to decrease at 4th months with a decrease compared to the 2nd month of 1.5±2.7 (p=0,000). Nijmegen nail psoriasis Activity Index Tool (N-NAIL) decreased statistically significantly at 2nd months with an average decrease of 8.4±8.3 (p=0.000) and continued to decrease at 4th month with a decrease compared to the 2nd month is 5.3±6.4 (p=0.000). Side effects are mainly local, including skin atrophy, vasodilation; 33 percent of female patients had menstrual disorder. None of patients had flare-ups.
Conclusion: Triamcinolone acetonide intralesional injection is a fairly safe method, helping to improve nail pitting and subungual hyperkeratosis at 2nd months and 4th months, but no difference between 2nd months and 4th months; other lesions do not change. This therapy also reduced NAPSI and N-NAIL scores at both 2nd and 4th months.
Article Details
Keywords
Nail matrix lesions, nail bed lesions, NAPSI, N-NAIL.
References
2. Armesto S, Esteve A, Coto-Segura P et al., Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients. Actas Dermosifiliogr. 2011:102:365-72.
3. Augustin M, Reich K, Blome C, et al., Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol; 2010:163:580-5
4. De Jong EMGJ, Seegers BAMPA, Gulinck MK et al., Psoriasis of the Nails Associated with Disability in a Large Number of Patients: Results of a Recent Interview with 1,728 Patients. Dermatology, 1996:193(4), 300–303. doi:10.1159/000246274.
5. Darjani A, Nafezi R, Moladoust H, Nail Involvements as an Indicator of Skin Lesion Severity in Psoriatic patients, Acta Dermatovenerol Croat. Dec; 2018:26(4):307-313.
6. Khawer S, Waqar A, Treatment of nail psoriasis with a modified regimen of steroid injections. J Coll Physicians Surg Pak; 2008:18(2):78-81.
7. Einapak B, Narumol S, Nasuda D et al., A Randomised Comparison of Efficacy and Safety of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails. Journal of Dermatological Treatment, 2018:45, p1473-1503.
8. Enjeksiyonlarının E, Güvenilirliğinin K, The Comparison of the Efficacy and Safety of Intralesional Triamcinolone Acetonide and Methotrexate Injections for the Treatment of Fingernail Psoriasis, Journal of Ankara University Faculty of Medicine;2018, 71(2):145-151
9. Melissa NB, Vincent R, Isabelle M et al., Treatment of Nail Psoriasis with Intralesional Triamcinolone Acetonide Using a Needle-Free Jet Injector: A Prospective Trial, Journal of Cutaneous Medicine and Surgery, 2013:18, pp 38-42.